Department Stores
Compare Stocks
2 / 10Stock Comparison
KSS vs DDS
Revenue, margins, valuation, and 5-year total return — side by side.
Department Stores
KSS vs DDS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Department Stores | Department Stores |
| Market Cap | $1.62B | $6.81B |
| Revenue (TTM) | $15.53B | $6.56B |
| Net Income (TTM) | $271M | $571M |
| Gross Margin | 36.1% | 38.3% |
| Operating Margin | 3.3% | 10.5% |
| Forward P/E | 10.3x | 16.9x |
| Total Debt | $2.45B | $358M |
| Cash & Equiv. | $674M | $862M |
KSS vs DDS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Kohl's Corporation (KSS) | 100 | 75.0 | -25.0% |
| Dillard's, Inc. (DDS) | 100 | 1904.3 | +1804.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: KSS vs DDS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
KSS is the clearest fit if your priority is value and momentum.
- Lower P/E (10.3x vs 16.9x)
- +128.8% vs DDS's +74.2%
DDS carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 12 yrs, beta 1.15, yield 5.4%
- Rev growth -0.4%, EPS growth -1.0%, 3Y rev CAGR -2.1%
- 9.2% 10Y total return vs KSS's -23.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -0.4% revenue growth vs KSS's -4.3% | |
| Value | Lower P/E (10.3x vs 16.9x) | |
| Quality / Margins | 8.7% margin vs KSS's 1.7% | |
| Stability / Safety | Beta 1.15 vs KSS's 2.32, lower leverage | |
| Dividends | 5.4% yield, 12-year raise streak, vs KSS's 3.4% | |
| Momentum (1Y) | +128.8% vs DDS's +74.2% | |
| Efficiency (ROA) | 16.3% ROA vs KSS's 2.0%, ROIC 29.7% vs 4.6% |
KSS vs DDS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
KSS vs DDS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
DDS leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
KSS is the larger business by revenue, generating $15.5B annually — 2.4x DDS's $6.6B. DDS is the more profitable business, keeping 8.7% of every revenue dollar as net income compared to KSS's 1.7%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $15.5B | $6.6B |
| EBITDAEarnings before interest/tax | $1.2B | $868M |
| Net IncomeAfter-tax profit | $271M | $571M |
| Free Cash FlowCash after capex | $1.2B | $620M |
| Gross MarginGross profit ÷ Revenue | +36.1% | +38.3% |
| Operating MarginEBIT ÷ Revenue | +3.3% | +10.5% |
| Net MarginNet income ÷ Revenue | +1.7% | +8.7% |
| FCF MarginFCF ÷ Revenue | +7.5% | +9.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -4.2% | -3.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +153.5% | -3.1% |
Valuation Metrics
KSS leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 6.1x trailing earnings, KSS trades at a 61% valuation discount to DDS's 15.7x P/E. On an enterprise value basis, KSS's 2.8x EV/EBITDA is more attractive than DDS's 7.3x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.6B | $6.8B |
| Enterprise ValueMkt cap + debt − cash | $3.4B | $6.3B |
| Trailing P/EPrice ÷ TTM EPS | 6.08x | 15.68x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.30x | 16.85x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 2.80x | 7.27x |
| Price / SalesMarket cap ÷ Revenue | 0.10x | 1.04x |
| Price / BookPrice ÷ Book value/share | 0.41x | 3.79x |
| Price / FCFMarket cap ÷ FCF | 1.46x | 10.93x |
Profitability & Efficiency
DDS leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
DDS delivers a 24.3% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $7 for KSS. DDS carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to KSS's 0.61x. On the Piotroski fundamental quality scale (0–9), KSS scores 7/9 vs DDS's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +6.9% | +24.3% |
| ROA (TTM)Return on assets | +2.0% | +16.3% |
| ROICReturn on invested capital | +4.6% | +29.7% |
| ROCEReturn on capital employed | +4.8% | +26.0% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.61x | 0.15x |
| Net DebtTotal debt minus cash | $1.8B | -$504M |
| Cash & Equiv.Liquid assets | $674M | $862M |
| Total DebtShort + long-term debt | $2.5B | $358M |
| Interest CoverageEBIT ÷ Interest expense | 2.17x | — |
Total Returns (Dividends Reinvested)
DDS leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DDS five years ago would be worth $64,567 today (with dividends reinvested), compared to $3,614 for KSS. Over the past 12 months, KSS leads with a +128.8% total return vs DDS's +74.2%. The 3-year compound annual growth rate (CAGR) favors DDS at 30.7% vs KSS's -3.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -31.9% | -10.2% |
| 1-Year ReturnPast 12 months | +128.8% | +74.2% |
| 3-Year ReturnCumulative with dividends | -9.4% | +123.5% |
| 5-Year ReturnCumulative with dividends | -63.9% | +545.7% |
| 10-Year ReturnCumulative with dividends | -23.7% | +918.4% |
| CAGR (3Y)Annualised 3-year return | -3.2% | +30.7% |
Risk & Volatility
DDS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
DDS is the less volatile stock with a 1.15 beta — it tends to amplify market swings less than KSS's 2.32 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DDS currently trades 77.0% from its 52-week high vs KSS's 57.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.32x | 1.15x |
| 52-Week HighHighest price in past year | $25.22 | $741.98 |
| 52-Week LowLowest price in past year | $6.47 | $343.12 |
| % of 52W HighCurrent price vs 52-week peak | +57.2% | +77.0% |
| RSI (14)Momentum oscillator 0–100 | 49.1 | 39.4 |
| Avg Volume (50D)Average daily shares traded | 4.6M | 102K |
Analyst Outlook
DDS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates KSS as "Hold" and DDS as "Hold". Consensus price targets imply 24.9% upside for KSS (target: $18) vs -2.9% for DDS (target: $555). For income investors, DDS offers the higher dividend yield at 5.44% vs KSS's 3.38%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $18.00 | $555.00 |
| # AnalystsCovering analysts | 39 | 13 |
| Dividend YieldAnnual dividend ÷ price | +3.4% | +5.4% |
| Dividend StreakConsecutive years of raises | 0 | 12 |
| Dividend / ShareAnnual DPS | $0.49 | $31.08 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
DDS leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). KSS leads in 1 (Valuation Metrics).
KSS vs DDS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is KSS or DDS a better buy right now?
For growth investors, Dillard's, Inc.
(DDS) is the stronger pick with -0. 4% revenue growth year-over-year, versus -4. 3% for Kohl's Corporation (KSS). Kohl's Corporation (KSS) offers the better valuation at 6. 1x trailing P/E (10. 3x forward), making it the more compelling value choice. Analysts rate Kohl's Corporation (KSS) a "Hold" — based on 39 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — KSS or DDS?
On trailing P/E, Kohl's Corporation (KSS) is the cheapest at 6.
1x versus Dillard's, Inc. at 15. 7x. On forward P/E, Kohl's Corporation is actually cheaper at 10. 3x.
03Which is the better long-term investment — KSS or DDS?
Over the past 5 years, Dillard's, Inc.
(DDS) delivered a total return of +545. 7%, compared to -63. 9% for Kohl's Corporation (KSS). Over 10 years, the gap is even starker: DDS returned +918. 4% versus KSS's -23. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — KSS or DDS?
By beta (market sensitivity over 5 years), Dillard's, Inc.
(DDS) is the lower-risk stock at 1. 15β versus Kohl's Corporation's 2. 32β — meaning KSS is approximately 102% more volatile than DDS relative to the S&P 500. On balance sheet safety, Dillard's, Inc. (DDS) carries a lower debt/equity ratio of 15% versus 61% for Kohl's Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — KSS or DDS?
By revenue growth (latest reported year), Dillard's, Inc.
(DDS) is pulling ahead at -0. 4% versus -4. 3% for Kohl's Corporation (KSS). On earnings-per-share growth, the picture is similar: Kohl's Corporation grew EPS 144. 3% year-over-year, compared to -1. 0% for Dillard's, Inc.. Over a 3-year CAGR, DDS leads at -2. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — KSS or DDS?
Dillard's, Inc.
(DDS) is the more profitable company, earning 8. 7% net margin versus 1. 8% for Kohl's Corporation — meaning it keeps 8. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DDS leads at 10. 5% versus 3. 3% for KSS. At the gross margin level — before operating expenses — DDS leads at 37. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is KSS or DDS more undervalued right now?
On forward earnings alone, Kohl's Corporation (KSS) trades at 10.
3x forward P/E versus 16. 9x for Dillard's, Inc. — 6. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KSS: 24. 9% to $18. 00.
08Which pays a better dividend — KSS or DDS?
All stocks in this comparison pay dividends.
Dillard's, Inc. (DDS) offers the highest yield at 5. 4%, versus 3. 4% for Kohl's Corporation (KSS).
09Is KSS or DDS better for a retirement portfolio?
For long-horizon retirement investors, Dillard's, Inc.
(DDS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 15), 5. 4% yield, +918. 4% 10Y return). Kohl's Corporation (KSS) carries a higher beta of 2. 32 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DDS: +918. 4%, KSS: -23. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between KSS and DDS?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.